Cost-effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in Portugal

Original language	English
Pages (from-to)	A532-A532
Journal	Value in Health
Volume	17
Issue number	7
DOIs	https://doi.org/10.1016/j.jval.2014.08.1693
Publication status	Published - Nov 2014

Access to Document

• 10.1016/j.jval.2014.08.1693Licence: Other

Cite this

• APA
• Author
• BIBTEX
• Harvard
• Standard
• RIS
• Vancouver

Augusto, M., Gouveia, M., Borges, M., & Campioni, M. (2014). Cost-effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in Portugal. Value in Health, 17(7), A532-A532. https://doi.org/10.1016/j.jval.2014.08.1693

Augusto, M. ; Gouveia, M. ; Borges, M. et al. / Cost-effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in Portugal. In: Value in Health. 2014 ; Vol. 17, No. 7. pp. A532-A532.

@article{74bc825e3bb543938b221575bb254bba,

title = "Cost-effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in Portugal",

author = "M. Augusto and M. Gouveia and M. Borges and M. Campioni",

year = "2014",

month = nov,

doi = "10.1016/j.jval.2014.08.1693",

language = "English",

volume = "17",

pages = "A532--A532",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier Ltd.",

number = "7",

}

Augusto, M, Gouveia, M, Borges, M & Campioni, M 2014, 'Cost-effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in Portugal', Value in Health, vol. 17, no. 7, pp. A532-A532. https://doi.org/10.1016/j.jval.2014.08.1693

Cost-effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in Portugal. / Augusto, M.; Gouveia, M.; Borges, M. et al.
In: Value in Health, Vol. 17, No. 7, 11.2014, p. A532-A532.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Cost-effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in Portugal

AU - Augusto, M.

AU - Gouveia, M.

AU - Borges, M.

AU - Campioni, M.

PY - 2014/11

Y1 - 2014/11

U2 - 10.1016/j.jval.2014.08.1693

DO - 10.1016/j.jval.2014.08.1693

M3 - Meeting Abstract

SN - 1098-3015

VL - 17

SP - A532-A532

JO - Value in Health

JF - Value in Health

IS - 7

ER -

Augusto M, Gouveia M, Borges M, Campioni M. Cost-effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in Portugal. Value in Health. 2014 Nov;17(7):A532-A532. doi: 10.1016/j.jval.2014.08.1693